Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_assertion description "[Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_assertion evidence source_evidence_literature NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_assertion SIO_000772 16224536 NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_assertion wasDerivedFrom befree-20140225 NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_assertion wasGeneratedBy ECO_0000203 NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP740347.RAt1t5VKZegk9ZGGzHQtGf_gVC1Rh4IZp1iKTa6doQ4b8130_provenance.